NASDAQ:EHTH - eHealth Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $17.29
  • Forecasted Upside: 55.31 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.13
▼ -0.09 (-0.80%)

This chart shows the closing price for EHTH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New eHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EHTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EHTH

Analyst Price Target is $17.29
▲ +55.31% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for eHealth in the last 3 months. The average price target is $17.29, with a high forecast of $28.00 and a low forecast of $10.00. The average price target represents a 55.31% upside from the last price of $11.13.

This chart shows the closing price for EHTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 investment analysts is to hold stock in eHealth. This rating has held steady since July 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
11/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
2/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings
8/20/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
11/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 9 hold ratings
  • 0 sell ratings
2/16/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
4/17/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
5/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/5/2022Deutsche Bank AktiengesellschaftLower Price Target$19.00 ➝ $10.00High
3/21/2022CitigroupDowngradeBuy ➝ Neutral$37.00 ➝ $15.00High
3/3/2022Credit Suisse GroupLower Price TargetNeutral$31.00 ➝ $16.00High
3/2/2022Craig HallumLower Price Target$33.00 ➝ $15.00High
3/2/2022Truist FinancialDowngradeBuy ➝ Hold$15.00Medium
1/18/2022BarclaysDowngradeOverweight ➝ Equal Weight$22.00Medium
1/7/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$45.00 ➝ $31.00High
12/20/2021CitigroupLower Price TargetBuy$45.00 ➝ $37.00Medium
11/29/2021Deutsche Bank AktiengesellschaftLower Price TargetHold$86.00 ➝ $19.00High
11/10/2021Credit Suisse GroupLower Price TargetOutperform$59.00 ➝ $45.00Low
11/9/2021Truist FinancialLower Price TargetBuy$100.00 ➝ $40.00Low
11/9/2021Craig HallumDowngradeBuy ➝ Hold$75.00 ➝ $33.00Low
11/9/2021Royal Bank of CanadaLower Price TargetSector Perform$62.00 ➝ $28.00Low
7/30/2021Craig HallumBoost Price TargetBuy$75.00 ➝ $85.00High
7/30/2021Credit Suisse GroupLower Price TargetOutperform$90.00 ➝ $75.00High
7/30/2021Royal Bank of CanadaLower Price TargetSector Perform$70.00 ➝ $62.00High
4/30/2021Credit Suisse GroupBoost Price TargetOutperform$78.00 ➝ $90.00Low
4/30/2021BarclaysBoost Price TargetPositive ➝ Overweight$75.00 ➝ $80.00High
3/31/2021The Goldman Sachs GroupReiterated RatingBuy ➝ Neutral$63.00Low
3/30/2021Craig HallumBoost Price TargetBuy$65.00 ➝ $85.00Low
3/25/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$63.00High
3/23/2021Credit Suisse GroupBoost Price TargetOutperform$63.00 ➝ $78.00High
3/23/2021Evercore ISIBoost Price TargetPositive ➝ Outperform$60.00 ➝ $80.00High
2/25/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Hold$63.00Medium
2/24/2021Raymond JamesReiterated RatingHoldMedium
2/19/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$124.00 ➝ $63.00High
2/2/2021The Goldman Sachs GroupLower Price TargetBuy$101.00 ➝ $64.00Low
2/1/2021Truist FinancialLower Price Target$200.00 ➝ $100.00Low
2/1/2021Craig HallumLower Price TargetBuy$150.00 ➝ $65.00Low
2/1/2021Raymond JamesDowngradeOutperform ➝ Market PerformLow
2/1/2021BarclaysLower Price TargetOverweight$115.00 ➝ $75.00Low
1/29/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformHigh
12/14/2020SVB LeerinkLower Price TargetOutperform$110.00 ➝ $105.00Low
10/23/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$138.00 ➝ $124.00High
10/2/2020Raymond JamesReiterated RatingBuyHigh
9/25/2020The Goldman Sachs GroupInitiated CoverageBuy$101.00High
9/8/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$110.00High
8/6/2020Credit Suisse GroupReiterated RatingBuy$130.00Low
7/27/2020Raymond JamesLower Price TargetOutperform$165.00 ➝ $115.00High
7/24/2020SunTrust BanksLower Price Target$250.00 ➝ $200.00Low
7/24/2020Craig HallumLower Price TargetBuy$200.00 ➝ $150.00High
7/24/2020Credit Suisse GroupLower Price TargetOutperform$174.00 ➝ $156.00High
7/24/2020SVB LeerinkBoost Price TargetMarket Perform$108.00 ➝ $110.00High
7/24/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$138.00 ➝ $170.00High
7/24/2020Royal Bank of CanadaBoost Price TargetOutperform$127.00 ➝ $166.00High
7/24/2020CitigroupLower Price TargetBuy$135.00 ➝ $125.00High
7/24/2020BarclaysLower Price TargetMarket Perform ➝ Overweight$150.00 ➝ $140.00High
7/14/2020CitigroupInitiated CoverageBuy$135.00High
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$108.00High
6/15/2020Evercore ISIInitiated CoverageBuy$150.00Low
4/29/2020Cantor FitzgeraldReiterated RatingBuy$185.00Low
4/27/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$177.00 ➝ $170.00High
4/24/2020SunTrust BanksReiterated RatingBuy$250.00High
4/24/2020Credit Suisse GroupInitiated CoverageBuy$174.00High
4/16/2020BarclaysInitiated CoverageOverweight$150.00Low
2/24/2020SunTrust BanksBoost Price TargetBuy$200.00 ➝ $250.00High
2/24/2020Credit Suisse GroupBoost Price TargetBuy ➝ Outperform$145.00 ➝ $179.00High
2/21/2020Craig HallumBoost Price TargetBuy$150.00 ➝ $200.00High
2/21/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$163.00 ➝ $177.00High
2/21/2020Royal Bank of CanadaBoost Price TargetOutperform$132.00 ➝ $166.00High
2/21/2020Cantor FitzgeraldReiterated RatingOverweight$150.00 ➝ $185.00High
2/18/2020SunTrust BanksReiterated RatingBuy$200.00Medium
1/28/2020Raymond JamesBoost Price TargetOutperform$90.00 ➝ $135.00Medium
1/24/2020Craig HallumBoost Price TargetBuy$110.00 ➝ $150.00High
1/24/2020Credit Suisse GroupBoost Price TargetOutperform$134.00 ➝ $145.00High
1/24/2020Royal Bank of CanadaBoost Price TargetOutperform$111.00 ➝ $132.00High
1/24/2020Cantor FitzgeraldReiterated RatingOverweight$120.00 ➝ $150.00High
1/17/2020SunTrust BanksReiterated RatingBuy$200.00High
10/25/2019Cantor FitzgeraldSet Price TargetBuy$120.00Low
10/25/2019Royal Bank of CanadaSet Price TargetBuy$111.00Low
10/25/2019Raymond JamesSet Price TargetBuy$90.00Low
10/14/2019Raymond JamesInitiated CoverageOutperform$90.00High
9/27/2019Evercore ISISet Price TargetBuy$125.00High
9/27/2019Credit Suisse GroupUpgradeOutperformMedium
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$173.00Low
9/6/2019SunTrust BanksSet Price TargetBuy$150.00High
8/6/2019Credit Suisse GroupBoost Price TargetOutperform$118.00 ➝ $136.00Medium
7/29/2019First AnalysisUpgradeOutperform ➝ Strong-Buy$106.00 ➝ $136.00Medium
7/26/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$89.00 ➝ $111.00High
7/26/2019SunTrust BanksBoost Price TargetBuy ➝ Positive$150.00High
7/26/2019Cantor FitzgeraldBoost Price TargetOverweight$100.00 ➝ $120.00High
7/19/2019First AnalysisInitiated CoverageOutperform ➝ Outperform$106.00Low
7/10/2019Credit Suisse GroupInitiated CoverageOutperform$104.00Medium
5/15/2019SunTrust BanksBoost Price TargetBuy$120.00High
5/8/2019Cantor FitzgeraldBoost Price TargetOverweight$87.00 ➝ $100.00Low
4/29/2019Cantor FitzgeraldReiterated RatingOverweight$73.00 ➝ $87.00Low
4/26/2019Royal Bank of CanadaSet Price TargetBuy$89.00Medium
4/26/2019Craig HallumReiterated RatingBuy$75.00 ➝ $85.00High
4/10/2019SunTrust BanksBoost Price TargetBuy$90.00Medium
2/22/2019SunTrust BanksBoost Price TargetPositive ➝ Buy$75.00High
2/20/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$57.00 ➝ $83.00Medium
2/4/2019Evercore ISIInitiated CoverageOutperform ➝ Outperform$75.00Medium
1/28/2019Craig HallumBoost Price TargetBuy$37.00 ➝ $75.00Low
1/24/2019Chardan CapitalReiterated RatingBuy ➝ Buy$40.00 ➝ $65.00High
1/23/2019SunTrust BanksBoost Price TargetPositive ➝ Buy$60.00High
1/23/2019Cantor FitzgeraldReiterated RatingOverweight$56.00High
12/20/2018SunTrust BanksBoost Price TargetBuy$50.00High
12/20/2018Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$57.00High
10/25/2018Cantor FitzgeraldReiterated RatingBuy$39.00High
10/8/2018Cantor FitzgeraldBoost Price TargetOverweight$39.00Low
8/16/2018Chardan CapitalInitiated CoverageBuy$40.00High
7/27/2018Cantor FitzgeraldReiterated RatingOverweight$26.00High
5/18/2018Cantor FitzgeraldBoost Price TargetOverweight$22.00High
3/6/2018Cantor FitzgeraldReiterated RatingBuy$20.00High
12/11/2017Craig HallumReiterated RatingBuy$28.00Low
10/30/2017Jefferies Financial GroupBoost Price TargetHold$20.00 ➝ $23.00N/A
10/27/2017SunTrust BanksReiterated RatingBuy$30.00N/A
10/20/2017SunTrust BanksReiterated RatingBuy$22.00N/A
10/19/2017Wells Fargo & CompanyBoost Price TargetMarket Perform$18.00 ➝ $24.00N/A
10/18/2017Cantor FitzgeraldReiterated RatingBuy$27.00N/A
10/2/2017Cantor FitzgeraldBoost Price TargetOverweight$21.00 ➝ $27.00High
8/26/2017Jefferies Financial GroupReiterated RatingHold$18.00 ➝ $20.00High
8/20/2017Jefferies Financial GroupBoost Price TargetHold$18.00 ➝ $20.00Low
7/27/2017Cantor FitzgeraldReiterated RatingBuy$20.00Low
7/14/2017Jefferies Financial GroupReiterated RatingHold$18.00Low
(Data available from 5/17/2017 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2021
  • 4 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
11/18/2021
  • 1 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/18/2021
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/17/2022
  • 4 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/16/2022
  • 3 very positive mentions
  • 20 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
3/18/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/17/2022
  • 5 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/17/2022

Current Sentiment

  • 5 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
eHealth logo
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company operates a marketplace that offers consumers a choice of insurance products, such as Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business, and other ancillary health insurance products from health insurance carriers. It markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers to market and distribute health insurance plans online; and provides online sponsorship and advertising, and lead referral services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $11.13
Low: $10.96
High: $11.78

50 Day Range

MA: $10.79
Low: $8.05
High: $13.24

52 Week Range

Now: $11.13
Low: $7.89
High: $66.49

Volume

494,945 shs

Average Volume

726,044 shs

Market Capitalization

$298.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Frequently Asked Questions

What sell-side analysts currently cover shares of eHealth?

The following sell-side analysts have issued research reports on eHealth in the last twelve months: Barclays PLC, Citigroup Inc., Craig Hallum, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Royal Bank of Canada, StockNews.com, TheStreet, Truist Financial Co., and Zacks Investment Research.
View the latest analyst ratings for EHTH.

What is the current price target for eHealth?

7 Wall Street analysts have set twelve-month price targets for eHealth in the last year. Their average twelve-month price target is $17.29, suggesting a possible upside of 55.3%. Royal Bank of Canada has the highest price target set, predicting EHTH will reach $28.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $10.00 for eHealth in the next year.
View the latest price targets for EHTH.

What is the current consensus analyst rating for eHealth?

eHealth currently has 7 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in EHTH, but not buy more shares or sell existing shares.
View the latest ratings for EHTH.

What other companies compete with eHealth?

How do I contact eHealth's investor relations team?

eHealth's physical mailing address is 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054. The financial services provider's listed phone number is (877) 456-7180 and its investor relations email address is [email protected] The official website for eHealth is www.ehealthinsurance.com. Learn More about contacing eHealth investor relations.